| Characteristics . | No DGF . | Group A (0–1 days) . | Group B (2–7 days) . | Group C (8–14 days) . | Group D (>14 days) . | . |
|---|---|---|---|---|---|---|
| N . | (n = 278) . | (n = 77) . | (n = 131) . | (n = 70) . | (n = 71) . | P-value . |
| Recipient factors | ||||||
| Age (years), mean (SD) | 53.7 (13.3) | 51.3 (14.9) | 55.4 (12.6) | 56.7 (13.5) | 56.3 (13.4) | 0.068 |
| Recipients ≥65 years, n (%) | 81 (29.1) | 18 (23.4) | 44 (33.6) | 28 (40.0) | 25 (35.2) | 0.186 |
| Male, n (%) | 142 (51.1) | 56 (72.7) | 79 (60.3) | 42 (60.0) | 42 (59.2) | 0.012 |
| Retransplantation, n (%) | 22 (7.9) | 9 (11.7) | 20 (15.3) | 9 (12.9) | 18 (25.4) | 0.003 |
| Time on dialysis (months), median (IQR) | 62.3 (33–90) | 81.4 (52–109) | 63.5 (45–89) | 77.6 (48–97) | 84.0 (51–108) | <0.001 |
| HLA mismatches, mean (SD) | 2.4 (1.7) | 2.6 (1.6) | 2.9 (1.8) | 3.1 (1.6) | 2.6 (1.6) | 0.019 |
| CIT (hours), median (IQR) | 10.6 (7.6–14.1) | 9.4 (7.5–13.3) | 11.7 (8–15.0) | 11.9 (8.8–17.4) | 12.2 (9.2–15.6) | 0.003 |
| Diabetes (all types), n (%) | 36 (12.9) | 12 (15.6) | 11 (8.4) | 9 (12.9) | 10 (14.1) | 0.529 |
| Donor factors | ||||||
| Age (years), mean (SD) | 53.6 (15.8) | 54.0 (15) | 55.0 (16.0) | 56.6 (15.6) | 56.2 (15.3) | 0.499 |
| Donors ≥65 years, n (%) | 84 (30.2) | 19 (24.7) | 45 (34.4) | 28 (40.0) | 23 (32.4) | 0.319 |
| Donor creatinine at transplantation, median (IQR) | 0.86 (0.68–1.15) | 0.93 (0.7–1.3) | 0.92 (0.68–1.39) | 1.0 (0.72–1.3) | 0.90 (0.77–1.37) | 0.177 |
| KDRI 2017, median (IQR) | 1.39 (1.08–2.06) | 1.45 (1.15–1.96) | 1.44 (1.14–2.13) | 1.55 (1.25–2.13) | 1.63 (1.28–2.12) | 0.081 |
| KDPI 2017, median (IQR) | 64 (37.5–93) | 68 (45–91) | 68 (44–94) | 75 (54–94) | 79 (56–94) | 0.088 |
| Number of dialyses, median (IQR) | – | 1 (1–1) | 2 (1–3) | 5 (4–6) | 10 (8–13) | <0.001 |
| Characteristics . | No DGF . | Group A (0–1 days) . | Group B (2–7 days) . | Group C (8–14 days) . | Group D (>14 days) . | . |
|---|---|---|---|---|---|---|
| N . | (n = 278) . | (n = 77) . | (n = 131) . | (n = 70) . | (n = 71) . | P-value . |
| Recipient factors | ||||||
| Age (years), mean (SD) | 53.7 (13.3) | 51.3 (14.9) | 55.4 (12.6) | 56.7 (13.5) | 56.3 (13.4) | 0.068 |
| Recipients ≥65 years, n (%) | 81 (29.1) | 18 (23.4) | 44 (33.6) | 28 (40.0) | 25 (35.2) | 0.186 |
| Male, n (%) | 142 (51.1) | 56 (72.7) | 79 (60.3) | 42 (60.0) | 42 (59.2) | 0.012 |
| Retransplantation, n (%) | 22 (7.9) | 9 (11.7) | 20 (15.3) | 9 (12.9) | 18 (25.4) | 0.003 |
| Time on dialysis (months), median (IQR) | 62.3 (33–90) | 81.4 (52–109) | 63.5 (45–89) | 77.6 (48–97) | 84.0 (51–108) | <0.001 |
| HLA mismatches, mean (SD) | 2.4 (1.7) | 2.6 (1.6) | 2.9 (1.8) | 3.1 (1.6) | 2.6 (1.6) | 0.019 |
| CIT (hours), median (IQR) | 10.6 (7.6–14.1) | 9.4 (7.5–13.3) | 11.7 (8–15.0) | 11.9 (8.8–17.4) | 12.2 (9.2–15.6) | 0.003 |
| Diabetes (all types), n (%) | 36 (12.9) | 12 (15.6) | 11 (8.4) | 9 (12.9) | 10 (14.1) | 0.529 |
| Donor factors | ||||||
| Age (years), mean (SD) | 53.6 (15.8) | 54.0 (15) | 55.0 (16.0) | 56.6 (15.6) | 56.2 (15.3) | 0.499 |
| Donors ≥65 years, n (%) | 84 (30.2) | 19 (24.7) | 45 (34.4) | 28 (40.0) | 23 (32.4) | 0.319 |
| Donor creatinine at transplantation, median (IQR) | 0.86 (0.68–1.15) | 0.93 (0.7–1.3) | 0.92 (0.68–1.39) | 1.0 (0.72–1.3) | 0.90 (0.77–1.37) | 0.177 |
| KDRI 2017, median (IQR) | 1.39 (1.08–2.06) | 1.45 (1.15–1.96) | 1.44 (1.14–2.13) | 1.55 (1.25–2.13) | 1.63 (1.28–2.12) | 0.081 |
| KDPI 2017, median (IQR) | 64 (37.5–93) | 68 (45–91) | 68 (44–94) | 75 (54–94) | 79 (56–94) | 0.088 |
| Number of dialyses, median (IQR) | – | 1 (1–1) | 2 (1–3) | 5 (4–6) | 10 (8–13) | <0.001 |
| Characteristics . | No DGF . | Group A (0–1 days) . | Group B (2–7 days) . | Group C (8–14 days) . | Group D (>14 days) . | . |
|---|---|---|---|---|---|---|
| N . | (n = 278) . | (n = 77) . | (n = 131) . | (n = 70) . | (n = 71) . | P-value . |
| Recipient factors | ||||||
| Age (years), mean (SD) | 53.7 (13.3) | 51.3 (14.9) | 55.4 (12.6) | 56.7 (13.5) | 56.3 (13.4) | 0.068 |
| Recipients ≥65 years, n (%) | 81 (29.1) | 18 (23.4) | 44 (33.6) | 28 (40.0) | 25 (35.2) | 0.186 |
| Male, n (%) | 142 (51.1) | 56 (72.7) | 79 (60.3) | 42 (60.0) | 42 (59.2) | 0.012 |
| Retransplantation, n (%) | 22 (7.9) | 9 (11.7) | 20 (15.3) | 9 (12.9) | 18 (25.4) | 0.003 |
| Time on dialysis (months), median (IQR) | 62.3 (33–90) | 81.4 (52–109) | 63.5 (45–89) | 77.6 (48–97) | 84.0 (51–108) | <0.001 |
| HLA mismatches, mean (SD) | 2.4 (1.7) | 2.6 (1.6) | 2.9 (1.8) | 3.1 (1.6) | 2.6 (1.6) | 0.019 |
| CIT (hours), median (IQR) | 10.6 (7.6–14.1) | 9.4 (7.5–13.3) | 11.7 (8–15.0) | 11.9 (8.8–17.4) | 12.2 (9.2–15.6) | 0.003 |
| Diabetes (all types), n (%) | 36 (12.9) | 12 (15.6) | 11 (8.4) | 9 (12.9) | 10 (14.1) | 0.529 |
| Donor factors | ||||||
| Age (years), mean (SD) | 53.6 (15.8) | 54.0 (15) | 55.0 (16.0) | 56.6 (15.6) | 56.2 (15.3) | 0.499 |
| Donors ≥65 years, n (%) | 84 (30.2) | 19 (24.7) | 45 (34.4) | 28 (40.0) | 23 (32.4) | 0.319 |
| Donor creatinine at transplantation, median (IQR) | 0.86 (0.68–1.15) | 0.93 (0.7–1.3) | 0.92 (0.68–1.39) | 1.0 (0.72–1.3) | 0.90 (0.77–1.37) | 0.177 |
| KDRI 2017, median (IQR) | 1.39 (1.08–2.06) | 1.45 (1.15–1.96) | 1.44 (1.14–2.13) | 1.55 (1.25–2.13) | 1.63 (1.28–2.12) | 0.081 |
| KDPI 2017, median (IQR) | 64 (37.5–93) | 68 (45–91) | 68 (44–94) | 75 (54–94) | 79 (56–94) | 0.088 |
| Number of dialyses, median (IQR) | – | 1 (1–1) | 2 (1–3) | 5 (4–6) | 10 (8–13) | <0.001 |
| Characteristics . | No DGF . | Group A (0–1 days) . | Group B (2–7 days) . | Group C (8–14 days) . | Group D (>14 days) . | . |
|---|---|---|---|---|---|---|
| N . | (n = 278) . | (n = 77) . | (n = 131) . | (n = 70) . | (n = 71) . | P-value . |
| Recipient factors | ||||||
| Age (years), mean (SD) | 53.7 (13.3) | 51.3 (14.9) | 55.4 (12.6) | 56.7 (13.5) | 56.3 (13.4) | 0.068 |
| Recipients ≥65 years, n (%) | 81 (29.1) | 18 (23.4) | 44 (33.6) | 28 (40.0) | 25 (35.2) | 0.186 |
| Male, n (%) | 142 (51.1) | 56 (72.7) | 79 (60.3) | 42 (60.0) | 42 (59.2) | 0.012 |
| Retransplantation, n (%) | 22 (7.9) | 9 (11.7) | 20 (15.3) | 9 (12.9) | 18 (25.4) | 0.003 |
| Time on dialysis (months), median (IQR) | 62.3 (33–90) | 81.4 (52–109) | 63.5 (45–89) | 77.6 (48–97) | 84.0 (51–108) | <0.001 |
| HLA mismatches, mean (SD) | 2.4 (1.7) | 2.6 (1.6) | 2.9 (1.8) | 3.1 (1.6) | 2.6 (1.6) | 0.019 |
| CIT (hours), median (IQR) | 10.6 (7.6–14.1) | 9.4 (7.5–13.3) | 11.7 (8–15.0) | 11.9 (8.8–17.4) | 12.2 (9.2–15.6) | 0.003 |
| Diabetes (all types), n (%) | 36 (12.9) | 12 (15.6) | 11 (8.4) | 9 (12.9) | 10 (14.1) | 0.529 |
| Donor factors | ||||||
| Age (years), mean (SD) | 53.6 (15.8) | 54.0 (15) | 55.0 (16.0) | 56.6 (15.6) | 56.2 (15.3) | 0.499 |
| Donors ≥65 years, n (%) | 84 (30.2) | 19 (24.7) | 45 (34.4) | 28 (40.0) | 23 (32.4) | 0.319 |
| Donor creatinine at transplantation, median (IQR) | 0.86 (0.68–1.15) | 0.93 (0.7–1.3) | 0.92 (0.68–1.39) | 1.0 (0.72–1.3) | 0.90 (0.77–1.37) | 0.177 |
| KDRI 2017, median (IQR) | 1.39 (1.08–2.06) | 1.45 (1.15–1.96) | 1.44 (1.14–2.13) | 1.55 (1.25–2.13) | 1.63 (1.28–2.12) | 0.081 |
| KDPI 2017, median (IQR) | 64 (37.5–93) | 68 (45–91) | 68 (44–94) | 75 (54–94) | 79 (56–94) | 0.088 |
| Number of dialyses, median (IQR) | – | 1 (1–1) | 2 (1–3) | 5 (4–6) | 10 (8–13) | <0.001 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
